Linezolid Intravenous in pharma franchise in Odisha

Linezolid Intravenous in PCD pharma franchise in Chandigarh

Linezolid Intravenous in top pharma company in Hubli-Dharwad

Linezolid Intravenous in pcd pharma supplier in Bhubaneswar

Linezolid Intravenous in phama franchise company in India
Linezolid Intravenous in phama distributor in Mysore

Home/Products /linezolid-intravenous-infusion-i-point-p-point-2mg-infusion-infusion

Linzoglad IV Infusion

Composition : Linezolid Intravenous Infusion I.P. 2mg Infusion

Dosage Form : Infusion

Packaging Type : vial

Packaging : 300ml

Price : ₹820/-

Linzoglad IV Infusion contains Linezolid, a potent antibiotic in the oxazolidinone class, formulated for intravenous administration. It is effective against a wide range of serious Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Linezolid works by inhibiting bacterial protein synthesis, thus preventing bacterial growth. It is typically reserved for use in hospital settings, especially in patients who require intravenous therapy due to the severity of their infection or the inability to take oral antibiotics.

Read More

About the Product

Linzoglad IV Infusion contains Linezolid, a potent antibiotic in the oxazolidinone class, formulated for intravenous administration. It is effective against a wide range of serious Gram-positive bacterial infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Linezolid works by inhibiting bacterial protein synthesis, thus preventing bacterial growth. It is typically reserved for use in hospital settings, especially in patients who require intravenous therapy due to the severity of their infection or the inability to take oral antibiotics.

Common side effects include headache, diarrhea, nausea, and vomiting. Serious side effects may include thrombocytopenia, anemia, or serotonin syndrome, especially when used with other serotonergic agents.

Linzoglad IV Infusion is indicated for the treatment of severe infections caused by Gram-positive bacteria, such as pneumonia, skin and soft tissue infections, and VRE-associated infections.

Use under strict medical supervision. Prolonged use may lead to the development of drug-resistant bacteria.

Store in a cool, dry place below 25°C. Once reconstituted, the infusion should be used immediately or within a specified time frame as per the instructions.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation